Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HPV-Related Vulvar Intraepithelial Neoplasia”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Not applicableLooking for participantsNCT03061435
What this trial is testing

Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer.

Who this might be right for
Vulvar CancerCervical CancerVulvar Dysplasia+4 more
Dr. Danielle Vicus 110
Early research (Phase 1)Study completedNCT03792516
What this trial is testing

Artesunate Ointment for the Treatment of High Grade Vulvar Intraepithelial Neoplasia (HSIL VIN2/3)

Who this might be right for
Vulvar DysplasiaHPV-Related Vulvar Intraepithelial NeoplasiaPreinvasive Vulvar Disease+2 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15
Large-scale testing (Phase 3)Study completedNCT00092521
What this trial is testing

Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED)

Who this might be right for
Cervical CancerGenital Warts
Merck Sharp & Dohme LLC 5,759
Testing effectiveness (Phase 2)Study completedNCT03180684
What this trial is testing

Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)

Who this might be right for
Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)Vulvar DysplasiaVulvar Intraepithelial Neoplasia (VIN)+4 more
Inovio Pharmaceuticals 33
Testing effectiveness (Phase 2)Study completedNCT02858310
What this trial is testing

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

Who this might be right for
Papillomavirus InfectionsCervical Intraepithelial NeoplasiaCarcinoma In Situ+2 more
National Cancer Institute (NCI) 224